{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:56:00Z","timestamp":1793933760495,"version":"4.8.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jns.2023.120866","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T22:10:24Z","timestamp":1698876624000},"page":"120866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment"],"prefix":"10.1016","volume":"454","author":[{"given":"Mariagiovanna","family":"Cozza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Amadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Boccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jns.2023.120866_bb0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.0b013e3181eee40f","article-title":"Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy","volume":"75","author":"Biffi","year":"2010","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0010","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1148\/rg.2016150172","article-title":"Multimodality review of amyloid-related diseases of the central nervous system","volume":"36","author":"Miller-Thomas","year":"2016","journal-title":"Radiographics."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0015","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2214\/ajr.182.6.1821547","article-title":"Routine use of gradient-echo MRI to screen for cerebral amyloid angiopathy in elderly patients","volume":"182","author":"Walker","year":"2004","journal-title":"AJR Am. J. Roentgenol."},{"issue":"9","key":"10.1016\/j.jns.2023.120866_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2377-9-3","article-title":"Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review","volume":"13","author":"Keage","year":"2009","journal-title":"BMC Neurol."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.22516","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"70","author":"Viswanathan","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/alz.12366","article-title":"Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis","volume":"18","author":"J\u00e4kel","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2023.120866_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-12-385883-2.00006-0","article-title":"Cerebral amyloid angiopathy","volume":"107","author":"Yamada","year":"2012","journal-title":"Prog Mol BiolTransl Sci."},{"key":"10.1016\/j.jns.2023.120866_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.630502","article-title":"APOE and Alzheimer\u2019s disease: from lipid transport to physiopathology and therapeutics","volume":"15","author":"Husain","year":"2021","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ana.410410607","article-title":"High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy","volume":"41","author":"Nicoll","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2023.120866_bb0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","article-title":"APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"8","key":"10.1016\/j.jns.2023.120866_bb0055","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.STR.27.8.1333","article-title":"Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy","volume":"27","author":"Greenberg","year":"1996","journal-title":"Stroke."},{"issue":"7","key":"10.1016\/j.jns.2023.120866_bb0060","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/NEN.0b013e31829a25b9","article-title":"APOE-\u03b52 and APOE-\u03b54 correlate with increased amyloid accumulation in cerebral vasculature","volume":"72","author":"Nelson","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2023.120866_bb0065","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/01.STR.30.8.1643","article-title":"Cerebral amyloid angiopathy\u2013related hemorrhage: interaction of APOE \u03b52 with putative clinical risk factors","volume":"30","author":"McCarron","year":"1999","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp-2013-306485","article-title":"APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis","volume":"85","author":"Rannikm\u00e4e","year":"2014","journal-title":"J NeurolNeurosurg Psychiatry."},{"issue":"11","key":"10.1016\/j.jns.2023.120866_bb0075","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1016\/j.neurobiolaging.2015.08.008","article-title":"APOE and cerebral amyloid angiopathy in community-dwelling older persons","volume":"36","author":"Yu","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00401-018-1866-3","article-title":"Patterns and severity of vascular amyloid in Alzheimer\u2019s disease associated with duplications and missense mutations in APP gene, down syndrome and sporadic Alzheimer\u2019s disease","volume":"136","author":"Mann","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5853\/jos.2015.17.1.17","article-title":"Cerebral amyloid angiopathy: emerging concepts","volume":"17","author":"Yamada","year":"2015","journal-title":"J Stroke."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0095","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/1073858420954811","article-title":"Cerebral amyloid angiopathy and blood-brain barrier dysfunction","volume":"27","author":"Gireud-Goss","year":"2021","journal-title":"Neuroscientist."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0100","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/CM9.0000000000001427","article-title":"Cerebral amyloid angiopathy-related inflammation: current status and future implications","volume":"134","author":"Wu","year":"2021","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-023-02751-8","article-title":"TGF-\u03b21 signalling in Alzheimer\u2019s pathology and cytoskeletal reorganization: a specialized tau perspective","volume":"20","author":"Kapoor","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.jns.2023.120866_bb0110","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12935-022-02572-4","article-title":"Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases","volume":"22","author":"Jin","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0120","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2353\/ajpath.2008.070620","article-title":"Neprilysin: an enzyme candidate to slow the progression of Alzheimer\u2019s disease","volume":"172","author":"El-Amouri","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jns.2023.120866_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170769","article-title":"The non-cardiovascular actions of ACE","volume":"152","author":"Cao","year":"2022","journal-title":"Peptides."},{"key":"10.1016\/j.jns.2023.120866_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.601320","article-title":"The role of basement membranes in cerebral amyloid Angiopathy","volume":"11","author":"Howe","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000369922","article-title":"Amyloid spells and high blood pressure: imminent danger?","volume":"7","author":"Caetano","year":"2015","journal-title":"Case Rep Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0140","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.112.195511","article-title":"Hypertension induces brain \u03b2-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature","volume":"60","author":"Carnevale","year":"2012","journal-title":"Hypertension."},{"issue":"10","key":"10.1016\/j.jns.2023.120866_bb0145","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3389\/fimmu.2019.01534","article-title":"Anti-A\u03b2 antibodies and cerebral amyloid angiopathy complications","volume":"4","author":"Chantran","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jns.2023.120866_bb0150","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1212\/WNL.0b013e3182a9f545","article-title":"A\u03b2-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis","volume":"81","author":"Salvarani","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2023.120866_bb0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association research roundtable workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"Pt 12","key":"10.1016\/j.jns.2023.120866_bb0160","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awn261","article-title":"Consequence of Abeta immunization on the vasculature of human Alzheimer\u2019s disease brain","volume":"131","author":"Boche","year":"2008","journal-title":"Brain."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","article-title":"Cerebral amyloid angiopathy: a systematic review","volume":"7","author":"Biffi","year":"2011","journal-title":"J. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2023.120866_bb0180","first-page":"321","article-title":"Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol. 118(1):115\u201330. doi:10.1007\/s00401-009-0501-8. Epub 2009 Feb 19","volume":"118","author":"Revesz","year":"2009","journal-title":"Erratum in: Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.jns.2023.120866_bb0185","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-2010-100816","article-title":"Amyloid-\u03b2 production via cleavage of amyloid-\u03b2 protein precursor is modulated by cell density","volume":"22","author":"Zhang","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5114\/pjp.2013.39334","article-title":"The development of cerebral amyloid angiopathy in cerebral vessels. A review with illustrations based upon own investigated post mortem cases","volume":"64","author":"Mendel","year":"2013","journal-title":"Pol. J. Pathol."},{"issue":"7","key":"10.1016\/j.jns.2023.120866_bb0195","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/brain\/awx047","article-title":"Emerging concepts in sporadic cerebral amyloid angiopathy","volume":"140","author":"Charidimou","year":"2017","journal-title":"Brain."},{"issue":"9","key":"10.1016\/j.jns.2023.120866_bb0200","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3233\/ADR-220055","article-title":"Updated outlook of cerebral amyloid Angiopathy and inflammatory subtypes: pathophysiology, clinical manifestations, diagnosis and management","volume":"6","author":"Singh","year":"2022","journal-title":"J Alzheimers Dis Rep."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1212\/WNL.56.4.537","article-title":"Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria","volume":"56","author":"Knudsen","year":"2001","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2023.120866_bb0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.pmbts.2019.05.012","article-title":"Acquired cerebral amyloid angiopathy: an emerging concept","volume":"168","author":"Yamada","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.jns.2023.120866_bb0220","article-title":"Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon","volume":"16","author":"Banerjee","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0225","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1148\/rg.265055090","article-title":"Cerebral amyloid angiopathy: CT and MR imaging findings","volume":"26","author":"Chao","year":"2006","journal-title":"Radiographics."},{"key":"10.1016\/j.jns.2023.120866_bb0230","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","article-title":"Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy","volume":"74","author":"Linn","year":"2010","journal-title":"Neurology."},{"issue":"8","key":"10.1016\/j.jns.2023.120866_bb0235","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0240","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1007\/s00415-023-11631-3","article-title":"Cerebral amyloid angiopathy: an update","volume":"270","author":"Schroeder","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2023.120866_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/1754-9485.12726","article-title":"Cerebral amyloid angiopathy: review of clinico-radiological features and mimics","author":"Sharma","year":"2018","journal-title":"J. Med. Imaging Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0250","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(18)30006-1","article-title":"The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study","volume":"17","author":"Rodrigues","year":"2018","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.jns.2023.120866_bb0255","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1161\/STROKEAHA.120.031264","article-title":"Sensitivity of the Edinburgh criteria for lobar intracerebral hemorrhage in hereditary cerebral amyloid Angiopathy","volume":"51","author":"Van Etten","year":"2020","journal-title":"Stroke."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0260","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jnnp-2011-300371","article-title":"The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis","volume":"83","author":"Samarasekera","year":"2012","journal-title":"J NeurolNeurosurg Psychiatry."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0265","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20596","article-title":"Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy","volume":"58","author":"Rosand","year":"2005","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0270","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2990.2010.01137.x","article-title":"Review: sporadic cerebral amyloid angiopathy","volume":"37","author":"Attems","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"11","key":"10.1016\/j.jns.2023.120866_bb0275","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1212\/WNL.0b013e3181d55efa","article-title":"Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies","volume":"74","author":"Kumar","year":"2010","journal-title":"Neurology."},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0280","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/jcbfm.2015.25","article-title":"Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami","volume":"35","author":"Mart\u00ednez-Lizana","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.jns.2023.120866_bb0285","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","article-title":"Microbleed study group. Cerebral microbleeds: a guide to detection and interpretation","volume":"8","author":"Greenberg","year":"2009","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0290","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/CIRCULATIONAHA.115.016261","article-title":"Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam study","volume":"132","author":"Akoudad","year":"2015","journal-title":"Circulation."},{"issue":"8","key":"10.1016\/j.jns.2023.120866_bb0295","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamaneurol.2016.1017","article-title":"Association of Cerebral Microbleeds with cognitive decline and dementia","volume":"73","author":"Akoudad","year":"2016","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0300","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3174\/ajnr.A0783","article-title":"Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy","volume":"29","author":"Linn","year":"2008","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0305","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/jnnp-2017-316368","article-title":"Acute convexity subarachnoid haemorrhage and cortical superficial siderosis in probable cerebral amyloid angiopathy without lobar haemorrhage","volume":"89","author":"Charidimou","year":"2018","journal-title":"J NeurolNeurosurg Psychiatry."},{"issue":"10","key":"10.1016\/j.jns.2023.120866_bb0310","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamaneurol.2020.1782","article-title":"Association between immunosuppressive treatment and outcomes of cerebral amyloid Angiopathy-related inflammation","volume":"77","author":"Regenhardt","year":"2020","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0315","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/STROKEAHA.121.035836","article-title":"Prevalence of clinical and neuroimaging markers in cerebral amyloid Angiopathy: A systematic review and Meta-analysis","volume":"53","author":"Malhotra","year":"2022","journal-title":"Stroke."},{"issue":"19","key":"10.1016\/j.jns.2023.120866_bb0320","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1212\/WNL.0000000000003197","article-title":"Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study","volume":"87","author":"Gurol","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2023.120866_bb0325","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nicl.2017.05.002","article-title":"Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update","volume":"15","author":"Farid","year":"2017","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.jns.2023.120866_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.783996","article-title":"Cerebrospinal fluid biomarkers in cerebral amyloid Angiopathy: new data and quantitative Meta-analysis","volume":"14","author":"Margraf","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0335","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ana.23845","article-title":"Pathogenesis of cerebral microbleeds: in vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment","volume":"73","author":"Park","year":"2013","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2023.120866_bb0340","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1212\/WNL.0000000000005030","article-title":"Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis","volume":"90","author":"Charidimou","year":"2018","journal-title":"Neurology."},{"issue":"9","key":"10.1016\/j.jns.2023.120866_bb0345","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1161\/STROKEAHA.114.005598","article-title":"Pathogenetical subtypes of recurrent intracerebral hemorrhage: designations by SMASH-U classification system","volume":"45","author":"Yeh","year":"2014","journal-title":"Stroke."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0350","first-page":"74","article-title":"Cerebral amyloid angiopathy: an important differential diagnosis of stroke in the elderly","volume":"22","author":"Azmin","year":"2015","journal-title":"Malays J Med Sci."},{"key":"10.1016\/j.jns.2023.120866_bb0355","series-title":"StatPearls [Internet]","article-title":"Cerebral amyloid angiopathy","author":"Kuhn","year":"2022"},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0360","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000508760","article-title":"Hypertension-related cerebral microbleeds","volume":"12","author":"Reddy","year":"2020","journal-title":"Case Rep Neurol."},{"issue":"2","key":"10.1016\/j.jns.2023.120866_bb0365","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/STROKEAHA.121.035019","article-title":"Cerebellar superficial siderosis in cerebral amyloid angiopathy","volume":"53","author":"Koemans","year":"2022","journal-title":"Stroke."},{"issue":"7","key":"10.1016\/j.jns.2023.120866_bb0370","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jamaneurol.2017.0439","article-title":"Population-based prevalence of cerebral cavernous malformations in older adults: mayo clinic study of aging","volume":"74","author":"Flemming","year":"2017","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0375","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13256-018-1655-6","article-title":"Cerebral amyloid angiopathy mimicking central nervous system metastases: a case report","volume":"12","author":"DeZorzi","year":"2018","journal-title":"J. Med. Case Rep."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0380","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001199-200307000-00003","article-title":"Diffuse axonal injury in head trauma","volume":"18","author":"Smith","year":"2003","journal-title":"J. Head Trauma Rehabil."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0385","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0039-1698033","article-title":"Nonneoplastic cystic lesions of the central nervous system-Histomorphological Spectrum: A study of 538 cases","volume":"10","author":"Bhatt","year":"2019","journal-title":"J Neurosci Rural Pract."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0390","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13244-021-00988-6","article-title":"Microbleeds show a characteristic distribution in cerebral fat embolism","volume":"12","author":"Giyab","year":"2021","journal-title":"Insights Imag."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0395","first-page":"7","article-title":"Radiation-induced microbleeds after cranial irradiation: evaluation by phase-sensitive magnetic resonance imaging with 3.0 tesla. Yonago","volume":"56","author":"Tanino","year":"2013","journal-title":"Acta Med. Austriaca"},{"issue":"11 Suppl 1","key":"10.1016\/j.jns.2023.120866_bb0400","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/01.STR.0000143224.36527.44","article-title":"Amyloid angiopathy-related vascular cognitive impairment","volume":"35","author":"Greenberg","year":"2004","journal-title":"Stroke."},{"issue":"22","key":"10.1016\/j.jns.2023.120866_bb0405","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","article-title":"Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons","volume":"85","author":"Boyle","year":"2015","journal-title":"Neurology."},{"issue":"8","key":"10.1016\/j.jns.2023.120866_bb0410","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/brain\/awac178","article-title":"Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline","volume":"145","author":"Rabin","year":"2022","journal-title":"Brain."},{"issue":"9","key":"10.1016\/j.jns.2023.120866_bb0415","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jacc.2017.07.724","article-title":"Cerebral amyloid Angiopathy: diagnosis, clinical implications, and management strategies in atrial fibrillation","volume":"70","author":"DeSimone","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0420","first-page":"384","article-title":"Angiopatia amiloide cerebrale e fibrillazione atriale: un pericoloso connubio [Cerebral amyloid angiopathy and atrial fibrillation: a dangerous union]","volume":"0","author":"Merella","year":"2019","journal-title":"G ItalCardiol (Rome)."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0425","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/17474930221144911","article-title":"Cerebral small vessel disease: recent advances and future directions","volume":"18","author":"Markus","year":"2023","journal-title":"Int. J. Stroke"},{"issue":"9","key":"10.1016\/j.jns.2023.120866_bb0430","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.radcr.2021.05.080","article-title":"Cerebral amyloid angiopathy related inflammation: a little known but not to be underestimated disease","volume":"6","author":"Grasso","year":"2021","journal-title":"Radiol Case Rep."},{"issue":"7","key":"10.1016\/j.jns.2023.120866_bb0435","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.STR.27.7.1155","article-title":"Immune reactions associated with cerebral amyloid angiopathy","volume":"27","author":"Yamada","year":"1996","journal-title":"Stroke."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0440","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp.2009.204180","article-title":"Cerebral amyloid angiopathy related inflammation: three case reports and a review","volume":"82","author":"Chung","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0445","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3988\/jcn.2022.0493","article-title":"Inflammatory cerebral amyloid Angiopathy: a broad clinical Spectrum","volume":"19","author":"de Souza","year":"2023","journal-title":"J. Clin. Neurol."},{"issue":"22","key":"10.1016\/j.jns.2023.120866_bb0450","article-title":"When brain biopsy solves the dilemma of diagnosing atypical cerebral amyoild angiopathy: a case report","volume":"4","author":"Alokley","year":"2021","journal-title":"Am J Case Rep."},{"issue":"12","key":"10.1016\/j.jns.2023.120866_bb0455","doi-asserted-by":"crossref","first-page":"e1265","DOI":"10.1212\/WNL.0000000000200892","article-title":"Association of Microglial Activation with Spontaneous ARIA-E and CSF levels of anti-A\u03b2 autoantibodies","volume":"99","author":"Piazza","year":"2022","journal-title":"Neurology."},{"issue":"14","key":"10.1016\/j.jns.2023.120866_bb0460","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.3390\/ijms22147710","article-title":"Blood-brain barrier and neurodegenerative diseases-modeling with iPSC-derived brain cells","volume":"22","author":"Wu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0465","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ana.23891","article-title":"Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA?","volume":"73","author":"Werring","year":"2013","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0470","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/nprot.2006.277","article-title":"2006. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain","volume":"1","author":"Wilcock","year":"2006","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0475","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/brainsci13050747","article-title":"Cerebral amyloid Angiopathy-related inflammation (CAA-rI): three heterogeneous case reports and a focused literature review","volume":"13","author":"Bozovic","year":"2023","journal-title":"Brain Sci."},{"issue":"9","key":"10.1016\/j.jns.2023.120866_bb0480","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1161\/STROKEAHA.115.010024","article-title":"Inflammatory cerebral amyloid angiopathy, amyloid-\u03b2-related angiitis, and primary angiitis of the central nervous system: similarities and differences","volume":"46","author":"Moussaddy","year":"2015","journal-title":"Stroke."},{"issue":"20","key":"10.1016\/j.jns.2023.120866_bb0485","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003613","article-title":"Imaging findings of cerebral amyloid Angiopathy, A\u03b2-related Angiitis (ABRA), and cerebral amyloid angiopathy-related inflammation: a single-institution 25-year experience","volume":"95","author":"Salvarani","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jns.2023.120866_bb0490","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nic.2021.02.003","article-title":"Imaging of spontaneous intracerebral hemorrhage","volume":"31","author":"Jain","year":"2021","journal-title":"Neuroimaging Clin. N. Am."},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0495","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","article-title":"Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer\u2019s disease","volume":"131","author":"Kalaria","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0500","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7861\/clinmedicine.14-3-255","article-title":"Cerebral amyloid angiopathy: a transient ischaemic attack mimic","volume":"14","author":"Illsley","year":"2014","journal-title":"Clin. Med. (Lond.)"},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0505","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00415-019-09558-9","article-title":"Clinical features distinguish cerebral amyloid angiopathy-associated convexity subarachnoid haemorrhage from suspected TIA","volume":"267","author":"Stanton","year":"2020","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0510","first-page":"38","article-title":"Antithrombotic therapy in patients with cerebral microbleeds","volume":"30","author":"Wilson","year":"2017","journal-title":"CurrOpin Neurol."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0515","first-page":"37","article-title":"Cerebral amyloid angiopathy in stroke medicine","volume":"114","author":"Block","year":"2017","journal-title":"DtschArztebl Int."},{"issue":"2","key":"10.1016\/j.jns.2023.120866_bb0520","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/STROKEAHA.117.016990","article-title":"Diagnosis of cerebral amyloid angiopathy: evolution of the boston criteria","volume":"49","author":"Greenberg","year":"2018","journal-title":"Stroke."},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0525","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.0000000000012234","article-title":"Cerebral amyloid angiopathy-related transient focal neurologic episodes","volume":"97","author":"Smith","year":"2021","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0530","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/STROKEAHA.119.024148","article-title":"Clinical relevance of cerebral small vessel diseases","volume":"1","author":"Pasi","year":"2020","journal-title":"Stroke."},{"issue":"10","key":"10.1016\/j.jns.2023.120866_bb0535","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.3390\/ijms21103435","article-title":"Understanding the pathophysiology of cerebral amyloid angiopathy","volume":"21","author":"Gatti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0540","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1747493020974464","article-title":"A practical approach to the management of cerebral amyloid angiopathy","volume":"16","author":"Kozberg","year":"2021","journal-title":"Int. J. Stroke"},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0545","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3233\/JAD-200473","article-title":"Alzheimer\u2019s disease: the link between amyloid-\u03b2 and neurovascular dysfunction","volume":"76","author":"Solis","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.jns.2023.120866_bb0550","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/acn3.469","article-title":"Efficacy and safety of anti-amyloid-\u03b2 immunotherapy for Alzheimer\u2019s disease: a systematic review and network meta-analysis","volume":"4","author":"Mo","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0555","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","article-title":"Anti-amyloid immunotherapies for Alzheimer\u2019s disease: A 2023 clinical update","volume":"20","author":"Yadollahikhales","year":"2023","journal-title":"Neurotherapeutics."},{"issue":"7","key":"10.1016\/j.jns.2023.120866_bb0560","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/brain\/awz142","article-title":"Persistent neuropathological effects 14 years following amyloid-\u03b2 immunization in Alzheimer\u2019s disease","volume":"142","author":"Nicoll","year":"2019","journal-title":"Brain."},{"issue":"2","key":"10.1016\/j.jns.2023.120866_bb0565","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/antib12020041","article-title":"Recent trends in active and passive immunotherapies of Alzheimer\u2019s disease","volume":"12","author":"Alshamrani","year":"2023","journal-title":"Antibodies (Basel)."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0570","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0575","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3233\/JAD-230164","article-title":"Effect of lecanemab in early Alzheimer\u2019s disease: mechanistic interpretation in the amyloid cascade hypothesis 2.0 perspective","volume":"93","author":"Volloch","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jns.2023.120866_bb0580","author":"Lilly"},{"key":"10.1016\/j.jns.2023.120866_bb0585","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"90","key":"10.1016\/j.jns.2023.120866_bb0590","article-title":"Passive Alzheimer\u2019s immunotherapy: a promising or uncertain option?","author":"H\u00f8ilund-Carlsen","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jns.2023.120866_bb0595","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"6","author":"Hampel","year":"2023","journal-title":"Brain."},{"issue":"9","key":"10.1016\/j.jns.2023.120866_bb0600","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3174\/ajnr.A7586","article-title":"T. Amyloid-related imaging abnormalities with emerging Alzheimer disease therapeutics: detection and reporting recommendations for clinical practice","volume":"43","author":"Cogswell","year":"2022","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0605","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac245","article-title":"Blood-brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy","volume":"4","author":"Kozberg","year":"2022","journal-title":"Brain Commun."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0610","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12782","article-title":"Dysfunction of the blood-brain barrier in Alzheimer\u2019s disease: evidence from human studies","volume":"48","author":"Kurz","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jns.2023.120866_bb0615","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship between amyloid-\u03b2 deposition and blood-brain barrier dysfunction in Alzheimer\u2019s disease","volume":"15","author":"Wang","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2023.120866_bb0620","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, aducanumab, and gantenerumab - binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease","volume":"20","author":"S\u00f6derberg","year":"2023","journal-title":"Neurotherapeutics."},{"issue":"5","key":"10.1016\/j.jns.2023.120866_bb0625","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.3390\/ijms24054367","article-title":"Aducanumab-Hope or disappointment for Alzheimer\u2019s disease","volume":"24","author":"Wojtunik-Kulesza","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2023.120866_bb0630","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0635","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/acn3.761","article-title":"Immunotherapy with ponezumab for probable cerebral amyloid angiopathy","volume":"6","author":"Leurent","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0640","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.jns.2023.120866_bb0645","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.wad.0000213845.28624.f4","article-title":"A phase 2 study of tramiprosate for cerebral amyloid angiopathy","volume":"20","author":"Greenberg","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"6","key":"10.1016\/j.jns.2023.120866_bb0650","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/ijms21061992","article-title":"Potential therapeutic approaches for cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"21","author":"Tanaka","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2023.120866_bb0655","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fnagi.2014.00187","article-title":"Amyloid-beta and Alzheimer\u2019s disease: the role of neprilysin-2 in amyloid-beta clearance","volume":"6","author":"Marr","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jns.2023.120866_bb0660","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","article-title":"Antisense oligonucleotides in therapy for neurodegenerative disorders","volume":"87","author":"Evers","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0665","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neuron.2019.10.033","article-title":"Vasomotion as a driving force for paravascular clearance in the awake mouse brain","volume":"105","author":"van Veluw","year":"2020","journal-title":"Neuron."},{"issue":"8","key":"10.1016\/j.jns.2023.120866_bb0670","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/hbm.25392","article-title":"Vascular origins of low-frequency oscillations in the cerebrospinal fluid signal in resting-state fMRI: interpretation using photoplethysmography","volume":"42","author":"Attarpour","year":"2021","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jns.2023.120866_bb0675","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-2094-10-39","article-title":"Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation","volume":"10","author":"Kimura","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"18","key":"10.1016\/j.jns.2023.120866_bb0680","doi-asserted-by":"crossref","first-page":"e1809","DOI":"10.1212\/WNL.0000000000012778","article-title":"Spontaneous ARIA-like events in cerebral amyloid angiopathy-related inflammation: a multicenter prospective longitudinal cohort study","volume":"97","author":"Antolini","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2023.120866_bb0685","article-title":"Amyloid \u03b2-related Angiitis causing coma responsive to immunosuppression","volume":"2012","author":"Weiss","year":"2012","journal-title":"Case Rep Pathol."},{"key":"10.1016\/j.jns.2023.120866_bb0690","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fneur.2014.00013","article-title":"Amyloid-Beta related angiitis of the central nervous system: case report and topic review","volume":"5","author":"Nouh","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2023.120866_bb0695","first-page":"1","article-title":"Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy\u2013 related inflammation","author":"Regenhardt","year":"2020","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.jns.2023.120866_bb0700","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1747493017741569","article-title":"Cerebral amyloid angiopathy associated with inflammation: A systematic review of clinical and imaging features and outcome","volume":"13","author":"Corovic","year":"2018","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jns.2023.120866_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577377","article-title":"Corticosteroids lead to short-term improvement in cerebral amyloid angiopathy-related inflammation","volume":"348","author":"Rempe","year":"2020","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23003271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23003271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:05:06Z","timestamp":1758384306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23003271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":141,"alternative-id":["S0022510X23003271"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120866","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120866"}}